About Cameron
Cameron Sivwright is a Senior Associate in the firm’s corporate and commercial practice.
Cameron has advised on a broad range of commercial matters, including public and private mergers and acquisitions, corporate restructuring and equity capital markets transactions.
Prior to joining the firm in 2021, Cameron worked as a solicitor in a mergers and acquisitions team of a prominent Sydney law firm.
Cameron holds a Bachelor of Commerce from the University of Western Australia and a Juris Doctor from the University of Sydney.
Practice focus
Cameron’s practice focuses on the following areas:
- public takeovers, schemes and mergers
- private mergers and acquisitions
- equity capital markets
- corporate restructuring transactions
- listed and non-listed corporate governance, compliance and advisory, and
- general commercial and corporate advice.
Experience
Cameron has acted in a range of corporate and commercial matters, including:
Private M&A transactions
- Retailors Ltd: in relation to its acquisition of Retail Prodigy Group Pty Ltd, the partner and operator of Nike and Samsung stores across Australia and New Zealand, and the online retail operator for Mattel in Australia
- InstantScripts: in relation to its $135 million sale to Australian Pharmaceutical Industries (a wholly-owned subsidiary of Wesfarmers Limited)
- Chargrill Charlie's: in relation to its sale to Craveable Brands
- A confidential client: on its strategic investment in a start-up established in conjunction with the investment
- Noumi Limited: in relation to the sale of its minority stake in Australian Fresh Milk Holdings to a related party of the company and New Hope Group
- A confidential client: on its strategic investment in an early-stage private equity fund, and
- A confidential client: on its proposed acquisition of assets being sold as part of a competitive sale process.
Equity capital markets
- carsales: in relation to its $500 million entitlement offer (with retail rights trading) to fund its acquisition of a further 30% stake in webmotors S.A, and
- Cromwell Property Group: in relation to its planned demerger and IPO of an externally managed ASX-listed office A-REIT.
Public M&A transactions
- Probiotec: in relation to its acquisition by Indonesian-listed company PT Pyridam Farma, by way of scheme of arrangement
- Access Intelligence: in relation to its acquisition of Isentia Group by way of scheme, as well as its acquisition of a ~19.5% pre-bid stake from a major shareholder, valuing Isentia at $67 million (EV)
- BINGO Industries: in relation to its $2.3 billion acquisition by way of scheme by MIRA and its managed funds, as well as its response to the approach from the CPE Capital / MIRA consortium
- Link Group: in relation to the $4 billion (EV) change of control approaches from the PEP / Caryle consortium and SS&C
- Capgemini: in relation to its $95.5 million acquisition of RXP Services by way of scheme, and
- Caltex Australia (now Ampol): on its response to the $10 billion (EV) Couche-Tard NBIO offer and EG Group’s rival bid.
Corporate restructuring transactions
- Metricon: in relation to its turnaround plans, and
- Cromwell Property Group: in relation to its planned demerger and IPO of an externally managed ASX-listed office A-REIT.
